Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Pediatr Hematol Oncol ; 32(6): 494-6, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20661159

RESUMEN

SUMMARY: A preterm neonate, born to consanguineous parents, presented with respiratory distress, intracerebral hemorrhage, and a silvery-gray sheen of the hair and eyelashes. Griscelli syndrome (GS) type 3 was diagnosed after the detection of a novel homozygous mutation of the melanophilin gene. Thus, only the hypopigmentation, but not the patient's other clinical features, were attributable to this form of GS. Differential diagnosis of the various forms of GS must be performed as early as possible as GS2 is associated with a life threatening but curable immune disorder.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/genética , Hemorragia Cerebral/genética , Piebaldismo/genética , Síndrome de Dificultad Respiratoria del Recién Nacido/genética , Preescolar , Diagnóstico Diferencial , Humanos , Recién Nacido , Recien Nacido Prematuro , Piebaldismo/fisiopatología , Nacimiento Prematuro , Síndrome
2.
Allergy Asthma Clin Immunol ; 1(4): 142-60, 2005 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-20529219

RESUMEN

Pediatric hemophagocytic syndrome (HS) is a severe and often fatal clinical disorder. This syndrome is frequently unrecognized, and thus, affected children may receive suboptimal management, leading to an increase in mortality. The purpose of this review is to provide a clinical guide to (1) the recognition of HS based on clinical, biologic, and pathologic features; (2) the identification of the primary cause of HS in a given affected child; and (3) the initiation of effective treatment in a timely manner.

3.
J Cell Biol ; 209(3): 435-52, 2015 May 11.
Artículo en Inglés | MEDLINE | ID: mdl-25940347

RESUMEN

During the late stages of the HIV-1 replication cycle, the viral polyprotein Pr55(Gag) is recruited to the plasma membrane (PM), where it binds phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and directs HIV-1 assembly. We show that Rab27a controls the trafficking of late endosomes carrying phosphatidylinositol 4-kinase type 2 α (PI4KIIα) toward the PM of CD4(+) T cells. Hence, Rab27a promotes high levels of PM phosphatidylinositol 4-phosphate and the localized production of PI(4,5)P2, therefore controlling Pr55(Gag) membrane association. Rab27a also controls PI(4,5)P2 levels at the virus-containing compartments of macrophages. By screening Rab27a effectors, we identified that Slp2a, Slp3, and Slac2b are required for the association of Pr55(Gag) with the PM and that Slp2a cooperates with Rab27a in the recruitment of PI4KIIα to the PM. We conclude that by directing the trafficking of PI4KIIα-positive endosomes toward the PM, Rab27a controls PI(4,5)P2 production and, consequently, HIV-1 replication.


Asunto(s)
Membrana Celular/metabolismo , VIH-1/fisiología , Fosfatidilinositol 4,5-Difosfato/metabolismo , Ensamble de Virus/fisiología , Replicación Viral/fisiología , Proteínas de Unión al GTP rab/metabolismo , Transporte Biológico Activo/genética , Membrana Celular/genética , Membrana Celular/virología , Endosomas/genética , Endosomas/metabolismo , Endosomas/virología , Humanos , Células Jurkat , Macrófagos/metabolismo , Macrófagos/virología , Proteínas de la Membrana/metabolismo , Antígenos de Histocompatibilidad Menor , Fosfatidilinositol 4,5-Difosfato/genética , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Productos del Gen gag del Virus de la Inmunodeficiencia Humana/genética , Productos del Gen gag del Virus de la Inmunodeficiencia Humana/metabolismo , Proteínas de Unión al GTP rab/genética , Proteínas rab27 de Unión a GTP
4.
Immunol Rev ; 203: 98-109, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15661024

RESUMEN

Severe combined immunodeficiencies (SCIDs) consist of genetically determined arrest of T-cell differentiation. Ten different molecular defects have now been identified, which all lead to early death in the absence of therapy. Transplantation of allogeneic hematopoietic stem cells (HSCT) can restore T-cell development, thus saving the lives of SCID patients. In this review, the different characteristics of HSCT are discussed along with the available data regarding the long-term outcome. Transient thymopoiesis caused by an exhaustion of donor progenitor cells and possibly a progressive loss of thymus function can lead to a progressive decline in T-cell functions. The preliminary results of gene therapy show the correction of two SCID conditions. Based on the assumption that long-lasting pluripotent progenitor cells are transduced, these data suggest that gene therapy could overcome the long-term recurrence of the T-cell immunodeficiency. SCID is thus a disease model for experimental therapy in the hematopoietic system.


Asunto(s)
Inmunodeficiencia Combinada Grave/inmunología , Inmunodeficiencia Combinada Grave/terapia , Terapia Genética , Trasplante de Células Madre Hematopoyéticas , Humanos , Tolerancia Inmunológica , Modelos Inmunológicos , Inmunodeficiencia Combinada Grave/genética , Linfocitos T/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA